Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
The poisons standard and herbal medicines

Braun L

(2009), J Complement Med , 8(1), 41-2, 59

Tallman lettering – sounds good but where is the evidence?

Van de Vreede M, McRae A, Wiseman M, Dooley MJ

(2009), J Pharm Pract Res , 39(1), 80-1

Australian and New Zealand Intensive Care Society meeting

Troung J

(2009), J Pharm Pract Res , 39(1), 78-9

Views of pharmacist prescribers, doctors and patients on pharmacist prescribing implementation

Stewart DC, George J, Bond CM, Diack HL, McCaig DJ, Cunningham S

(2009), Int J Pharm Pract, 17(2), 89-94

Cross sectional survey of the Scottish general public's awareness of, views on, and attitudes toward nonmedical prescribing

Stewart DC, George J, Diack HL, Bond CM, McCaig DJ, Cunningham IS, Munro K, Pfleger D

(2009), Ann Pharmacother, 43(6), 1115-21

Thiopurine methyltransferase and thiopurine metabolite testing in patients with inflammatory bowel disease who are taking thiopurine drugs

Sheffield LJ, Irving P, Gupta A, Byron K, Macrae FA, Phillimore H, Dronavalli M, Rose R, George P, Walmsley T, Dixon B, Poole S, Dooley M, Sparrow M

(2009), Pharmacogenomics, 10(7), 1091-9

Impact of nurse education on the incidence of omitted medication doses

O’Shea TJ, Apalding AR, Carter FA

(2009), J Pharm Pract Res , 39(2), 114-6

Penetration of 1% voriconazole eye drops into human vitreous humour: a prospective, open-label study

Lau D, Leung L, Ferdinands M, Allen PJ, Fullinfaw RO, Davies GE, Kong DC

(2009), Clin Exp Ophthalmol, 37(2), 197-200

Oncology pharmacy preparatory review course

Larizza M

(2009), J Pharm Pract Res , 39(4), 333-4

Individualised foreign language medication lists for non-English speaking hospital patients

Larizza MA, Wilson R, Dooley MJ

(2009), J Pharm Pract Res , 39(4), 277-80

Assessing medication knowledge of Australian palliative cancer care patients and caregivers and their interactions with pharmacists

Hussainy SY, Marriott JL, Nation RL

(2009), Palliat Med, 12(9), 769

The management of prolonged, isolated hyperbilirubinemia following cytarabine-based chemotherapy for acute myeloid leukaemia

Coutsouvelis J, Corallo CE

(2009), J Oncol Pharm Pract, 15(2), 107-10

Anticholinergic syndrome following an unintentional overdose of scopolamine

Corallo CE, Whitfield A, Wu A

(2009), Ther Clin Risk Manag, 5(5), 719-23

Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia

Al-Badriyeh D, Liew D, Stewart K, Kong DC

(2009), J Antimicrob Chemother, 63(1), 197-208

Economic impact of caspofungin as compared with liposomal amphotericin B for empirical therapy in febrile neutropenia in Australia

Al-Badriyeh D, Liew D, Stewart K, Kong DC

(2009), J Antimicrob Chemother, 63(6), 1276-85

Intravenous olanzapine--another option for the acutely agitated patient?

Chan EW, Knott JC, Taylor DM, Phillips GA, Kong DC

(2009), Emerg Med Australas, 21(3), 241-2

Successful salvage treatment of Scedosporium apiospermum keratitis with topical voriconazole after failure of natamycin

Al-Badriyeh D, Leung L, Davies GE, Stewart K, Kong D

(2009), Ann Pharmacother, 43(6), 1139-42

Stability of extemporaneously prepared voriconazole ophthalmic solution

Al-Badriyeh D, Li J, Stewart K, Kong DC, Leung L, Davies GE, Fullinfaw R

(2009), Am J Health Syst Pharm, 66(16), 1478-83

Prospective open-label study of the administration of two-percent voriconazole eye drops

Al-Badriyeh D, Leung L, Roydhouse T, Fullinfaw R, Daniell M, Davies GE, Stewart K, Kong DC

(2009), Antimicrob Agents Chemother, 53(7), 3153-5

Successful use of topical voriconazole 1% alone as first-line antifungal therapy against Candida albicans keratitis

Al-Badriyeh D, Leung L, Davies GE, Stewart K, Kong D

(2009), Ann Pharmacother, 43(12), 2103-7

25 26 27 28 29